While acute hepatitis B infection is often resolved by the immune system, CHB occurs when the body's defences are unable to ...

Researchers at Oregon Health & Science University have developed the first transgenic nonhuman primate model—genetically modified to carry a human gene—for studying hepatitis B virus.

Aligos Therapeutics is a clinical-stage biotechnology company focused on improving patient outcomes through best-in-class ...

Hepatitis B can lead to liver disease. But we can prevent and manage this viral infection. Here’s what we know about the ...

At least one-third of the world's population has been infected with the hepatitis B virus (HBV), and 400 million people are chronic carriers. In most populations, chronic HBV infection is the ...

“His interest in epigenetic regulation in pathogens immediately made me consider HBV an ideal model system for him ... of the main challenges with treating hepatitis B is that the existing treatments ...

"Our hepatitis model may reveal how TSCMs differentiate ... More information: Hepatitis B virus-specific human stem cell memory T cells differentiate into cytotoxic T cells and eradicate HBV ...

Scientists from the Institut Pasteur, in collaboration with Kumamoto University in Japan, have assessed a new rapid diagnostic test to identify pregnant women at elevated risk of transmitting ...

The American Gastroenterological Association (AGA) has released an updated clinical practice guideline on the prevention of hepatitis B virus reactivation (HBVr) in at-risk persons. The document ...

Hepatitis B is a liver infection cause by the hepatitis B virus (HBV), and long-term hepatitis B infections that last longer ...

Hepatitis B is a liver inflammation caused by the hepatitis B virus (HBV). It is the second-leading infectious cause of death globally after tuberculosis. Prevention of mother-to-child ...